Cargando…

Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis

The optimal dose of vancomycin in critically ill patients receiving continuous venovenous hemofiltration (CVVH) remains unclear. The objective of this study was to identify factors that significantly affect pharmacokinetic profiles and to further investigate the optimal dosage regimens for criticall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chuhui, Zhang, Chao, Li, Xiaoxiao, Zhao, Sixuan, He, Na, Zhai, Suodi, Ge, Qinggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614878/ https://www.ncbi.nlm.nih.gov/pubmed/34827330 http://dx.doi.org/10.3390/antibiotics10111392

Ejemplares similares

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
por: Zhao, Sixuan, et al.
Publicado: (2021)

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization
por: Zhang, Yahui, et al.
Publicado: (2021)

Impact of CVVH on monocyte activation in the critically ill
por: Rokyta, R, et al.
Publicado: (2000)

Correction to: Amino acid loss during CVVH in critically ill patients
por: Stapel, S. N., et al.
Publicado: (2018)

The removal of antibiotics during continuous venovenous hemofiltration (CVVH) in critically ill patients with acute renal failure: measured versus estimated CVVH clearance
por: Bouman, C, et al.
Publicado: (2005)

A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia
por: He, Na, et al.
Publicado: (2020)

Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach
por: Maguigan, Kelly L., et al.
Publicado: (2021)

Pharmacodynamic Target Attainment for Meropenem and Piperacillin/Tazobactam Using a PK/PD-based Dosing Calculator in Critically Ill Patients
por: Heil, Emily, et al.
Publicado: (2017)

Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach
por: Coste, Anne, et al.
Publicado: (2023)

Vancomycin is commonly under‐dosed in critically ill children and neonates
por: Sosnin, Natasha, et al.
Publicado: (2019)

PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration
por: Akashita, Gaku, et al.
Publicado: (2015)

CVVH versus IHD in patients with multiple organ failure
por: Gašparović, V, et al.
Publicado: (2003)

Coupled Plasma Filtration Adsorption (CPFA) plus Continuous Veno-Venous Haemofiltration (CVVH) versus CVVH alone as an adjunctive therapy in the treatment of sepsis
por: Hassan, Juita, et al.
Publicado: (2013)

Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19
por: Lin, Jui-Hsiang, et al.
Publicado: (2020)

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets
por: Zhou, Yu-Feng, et al.
Publicado: (2020)

PK/PD modeling supports the dose-escalation decision in VIKING
por: Lovern, M, et al.
Publicado: (2010)

2953. PK/PD Comparison of a New Dosing Scheme for Meropenem Adapted to Outpatient Parenteral Antimicrobial Therapy (OPAT) in Non-Critically-Ill Patients
por: Briquet, Caroline, et al.
Publicado: (2023)

Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction
por: Ahmad, Ijaz, et al.
Publicado: (2016)

PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against Streptococcus suis in Piglets
por: Huang, Anxiong, et al.
Publicado: (2022)

Evaluation of the predilution technique in reducing the occurrence of bleeding during continuous venovenous haemofiltration in critically ill patients. Efficacy of predilution in reducing the amount of anticoagulation during CVVH
por: Honore, PM, et al.
Publicado: (1997)

Clinical CVVH model removes endothelium-derived microparticles from circulation
por: Abdelhafeez, Abdelhafeez H., et al.
Publicado: (2014)

Model‐Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin
por: Sou, Tomás, et al.
Publicado: (2020)

Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
por: Ahmad, Ijaz, et al.
Publicado: (2015)

Corrigendum to “Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction”
por: Ahmad, Ijaz, et al.
Publicado: (2017)

Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies
por: San Martín, Betty, et al.
Publicado: (2019)

Comment on “Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction”
por: Benini, Anna, et al.
Publicado: (2017)

The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients
por: Chen, Jihui, et al.
Publicado: (2021)

Vancomycin as a single daily dose in critically ill patients on an intensive care unit
por: Grundler, S, et al.
Publicado: (2000)

A higher dose of vancomycin is needed in critically ill patients with augmented renal clearance
por: He, Juan, et al.
Publicado: (2020)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
por: Garreau, Romain, et al.
Publicado: (2021)

A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide(®)) to the innovator brand in critically ill patients
por: Mer, Mervyn, et al.
Publicado: (2016)

Vancomycin dosing in patients undergoing maintenance hemodialysis
por: Rymarz, Aleksandra, et al.
Publicado: (2014)

Effect of vancomycin loading dose on clinical outcome in critically ill patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Yoon, Jin Gu, et al.
Publicado: (2021)

Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients
por: Schaefer, RM, et al.
Publicado: (2001)

Early application of CVVH In the complex treatment of patients with early severe acute pancreatitis
por: Aleksandrova, I, et al.
Publicado: (2012)

Regional citrate anticoagulation with a low-concentration solution in predilution-postdilution CVVH
por: Pistolesi, V, et al.
Publicado: (2012)

Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness
por: Baron, Jeffrey, et al.
Publicado: (2018)

Ceftobiprole: pharmacokinetics and PK/PD profile
por: Azanza Perea, José Ramón, et al.
Publicado: (2019)

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
por: Xiao, Xia, et al.
Publicado: (2015)

A Systematic Review on Clinical Safety and Efficacy of Vancomycin Loading Dose in Critically Ill Patients
por: Haseeb, Abdul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gd5cg9rrm4v0s0rgf9j32ai1d4